AdvaMedDx has elected new members to its board of directors, including Luminex CEO Patrick Balthrop; John Coulter, VP of molecular diagnostics at Abbott Laboratories; Rohan Hastie, general manager of diagnostics at Hologic; and Robert Greczyn, interim president and CEO of LipoScience.
Transgenomic announced that Paul Kinnon has been named president, CEO, and a director of the company, replacing Craig Tuttle. Kinnon joins Transgenomic from New Zealand-based ZyGem, where he served as president and CEO. Kinnon joined ZyGem in 2007 from Invitrogen, where he held the positions of vice president of global strategic alliances and vice president and general manager of the applied markets business unit. Prior to that, Kinnon held business, sales, and marketing roles at Guava Technologies (now part of Millipore), Cellomics (now part of Thermo Fisher Scientific), and other life science companies.